HoldsUp

Anna Lembke

Stanford University School of Medicine

Anna Lembke is a Professor of Psychiatry at the Stanford University School of Medicine and chief of the Stanford Addiction Medicine Dual Diagnosis Clinic. Her work centers on addiction medicine, psychiatry, and dopamine-related behaviors, and she is the author of 'Dopamine Nation: Finding Balance in the Age of Indulgence'. Her published research focuses on substance use disorders, examining treatments for opioid and alcohol dependence, associated cardiovascular risks, and the use of machine learning and social media data to monitor addiction trends.

40 claims checked on air: 3 context 1 contradicted 2 overstated 29 supported 5 unverified 3 flagged

What they said on air - supported

0:00:00supportedvery lowDopamine Expert: Doing This Once A Day Fixes Your Dopamine!

Rats genetically engineered to lack dopamine will consume food placed directly in their mouth, but will starve to death if food is placed even a body length away.

"There's a very famous experiment in which rats were engineered to have no dopamine, and the scientists discovered that if they put food in the rat's mouth, the rat would eat, but if you put the food even a body length away, the rat will starve to death" (said at 0:00:00)

The speaker accurately describes the classic findings from rodent models of dopamine deficiency (first genetically developed in mice by Zhou and Palmiter in 1995, and chemically modeled via 6-OHDA neurotoxic lesions in rats). Genetically engineered dopamine-deficient mice lack the motivation to seek food, exhibiting severe aphagia and adipsia that leads to starvation unless rescued (e.g., with L-DOPA injections), yet they retain normal hedonic responses (taste reactivity) and will ingest food or sucrose solutions delivered directly to their mouths. Because the evidence comes from mechanistic animal models, the GRADE certainty is very low.

0:00:54supportedhighDopamine Expert: Doing This Once A Day Fixes Your Dopamine!

The brain processes pleasure and pain within the same anatomical neural regions.

"One of the most important findings in neuroscience in the past 75 years is that the same parts of the brain that process pleasure also process pain" (said at 0:00:54)

Extensive neuroimaging and neurobiological evidence confirms that pleasure and pain share overlapping anatomical substrates and neurochemical systems within the brain. Key structures including the nucleus accumbens, anterior cingulate cortex, insular cortex, amygdala, prefrontal cortex, and periaqueductal gray are involved in processing both painful and rewarding/pleasant stimuli, largely mediated by common dopaminergic and opioid pathways.

0:08:23supportedhighDopamine Expert: Doing This Once A Day Fixes Your Dopamine!

Parkinson's disease is caused by dopamine depletion in the substantia nigra region of the brain.

"Parkinson's disease, which is a disease related to stiffness and tremor, is caused by a depletion of dopamine in a part of the brain called the substantia nigra. And as dopamine gets depleted in that part of the brain, people lose the ability to move their bodies." (said at 0:08:23)

The speaker's statement accurately reflects the established pathophysiology of Parkinson's disease. Parkinson's disease is a progressive neurodegenerative movement disorder characterized by cardinal motor symptoms including rigidity (stiffness), resting tremor, and bradykinesia (impaired/slowed movement). Its primary neuropathological hallmark is the progressive loss of dopaminergic neurons in the substantia nigra pars compacta, resulting in striatal dopamine depletion and subsequent dysfunction in motor control circuits.

0:12:25supportedhighDopamine Expert: Doing This Once A Day Fixes Your Dopamine!

Alcohol acts through endogenous opioid and GABA receptor systems to stimulate dopamine release in the reward pathway.

"alcohol works through its own chemical pathway. It works on our endogenous opioid system, the opioids that we make—we have receptors for opioids in our brains. It works on our endogenous GABA system, which is our calming neurotransmitter. And at the end of the day, it releases dopamine in the reward pathway." (said at 0:12:25)

The statement accurately reflects established neurobiological mechanisms of ethanol action. Alcohol exerts primary pharmacological actions on GABAergic systems (facilitating inhibitory/calming neurotransmission and disinhibitory circuits in the ventral tegmental area) and engages the endogenous opioid system. Pharmacological studies demonstrate that ethanol-induced activation of mu-opioid receptors and modulation of GABAergic transmission directly stimulate dopamine release within the mesolimbic reward pathway.

0:15:48supportedhighDopamine Expert: Doing This Once A Day Fixes Your Dopamine!

In response to elevated dopamine transmission, the brain downregulates signaling by internalizing (involuting) postsynaptic dopamine receptors.

"our brain will try to compensate or adapt to increased dopamine firing by downregulating dopamine transmission, for example, by involuting postsynaptic dopamine receptors." (said at 0:15:48)

Postsynaptic dopamine receptors belong to the G protein-coupled receptor (GPCR) superfamily. In response to sustained or elevated agonist activation (such as increased dopamine firing), GPCRs canonically undergo homologous desensitization, arrestin recruitment, and endocytic internalization (involuntary removal from the cell surface), which downregulates downstream signaling.

0:26:38supportedmoderateDopamine Expert: Doing This Once A Day Fixes Your Dopamine!

Individuals with co-occurring psychiatric disorders are at an increased risk of developing addiction.

"And we know that people with co-occurring psychiatric disorders, for example, are at increased risk of developing addiction, probably because they're reaching for that substance to self-medicate their psychiatric problem." (said at 0:26:38)

Large-scale epidemiological studies, such as the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC; N=43,093), demonstrate strong, statistically significant associations between independent psychiatric conditions (including mood, anxiety, and personality disorders) and the risk of developing substance abuse and dependence.

0:29:17supportedvery lowDopamine Expert: Doing This Once A Day Fixes Your Dopamine!

Laboratory rodents provided with self-administered cocaine will repeatedly press a lever for the drug until reaching exhaustion or death.

"first of all, rodents very easily get addicted to cocaine. They will press a lever for cocaine until exhaustion or death." (said at 0:29:17)

Laboratory animal studies demonstrate that when rats are given continuous, unlimited access to intravenous cocaine via lever pressing, they engage in severe episodic binges of drug self-administration alternating with brief periods of abstinence. Under these continuous-access conditions, the animals show severe physical deterioration, cessation of normal grooming, substantial weight loss (up to 47%), and high mortality (a 90% mortality rate within 30 days). Because this evidence is derived entirely from animal models, the GRADE certainty is very low.

0:29:22supportedvery lowDopamine Expert: Doing This Once A Day Fixes Your Dopamine!

In rodent experiments where cocaine self-administration has been extinguished, applying a severe physical stressor such as a painful foot shock causes the rodent to immediately resume lever-pressing for cocaine.

"if that cocaine is then taken away, that behavior will extinguish, which means that the mice will eventually just stop pressing the lever, right? Because they're not getting any cocaine... But if they're then exposed to a very painful foot shock, right? So a very extreme physical pain, which you could equate to a serious life stressor, the first thing the rat will do is run over to the lever and start pressing for cocaine" (said at 0:29:22)

Extensive preclinical literature establishes that in rodents trained to self-administer cocaine whose drug-seeking behavior has undergone extinction, exposure to an acute physical stressor—most commonly intermittent electric footshock—reliably reinstates lever-pressing behavior previously associated with drug delivery (the stress-induced reinstatement model of relapse). As this evidence is derived from animal models, the GRADE certainty is rated as very low.

0:32:10supportedmoderateDopamine Expert: Doing This Once A Day Fixes Your Dopamine!

Consuming excessive amounts of water can cause hyponatremia that leads to delirium.

"she discovered that by drinking copious amounts of water, she could become hyponatremic, meaning that she could lower the sodium levels in her bloodstream, which would then lead her to become delirious." (said at 0:32:10)

Consuming excessive amounts of water (such as in psychogenic polydipsia or water intoxication) can overwhelm renal excretory capacity and cause dilutional hyponatremia (a fall in serum sodium levels). Acute or severe hyponatremia leads to cerebral edema and acute metabolic encephalopathy, manifesting clinically as delirium, altered mental status, seizures, coma, or death.

0:35:10supportedhighDopamine Expert: Doing This Once A Day Fixes Your Dopamine!

There are no biological measurements, brain scans, or blood tests to clinically diagnose addiction.

"And you know, if and when it tips over into what we would call addiction, there's not a brain scan or a blood test to assess that. It's not like switching a light switch and it's like, "Oh yeah, now you have addiction." It's not like that. It's often a gradual and insidious thing. And we don't, in fact, have a biological measurement of addiction; we base it on what we call phenomenology, which is patterns of behavior that repeat themselves across time." (said at 0:35:10)

The speaker's assertion is correct. Diagnostic frameworks for substance use disorders and addiction (such as the DSM-5) rely on clinical phenomenology and behavioral criteria (e.g., impaired control, social impairment, risky use, and pharmacological criteria) rather than objective biological tests. While candidate neuroimaging markers (neuromarkers) and peripheral biomarkers are being actively researched, there are currently no clinically validated brain scans or blood tests used to diagnose addiction in routine clinical practice. Recent medical literature confirms that although neuroimaging and molecular markers for addiction are under development to better understand the neurobiological basis of substance use disorders, clinical diagnosis remains strictly based on behavioral assessments and patient-reported symptoms (PMID: 38630190, PMID: 35040765).

0:35:46supportedhighDopamine Expert: Doing This Once A Day Fixes Your Dopamine!

Addiction is defined clinically as the continued, compulsive use of a substance or behavior despite harm to self or others.

"And broadly speaking, the definition of addiction is the continued, compulsive use of a substance or a behavior despite harm to self and/or others." (said at 0:35:46)

The speaker's definition aligns with major clinical and diagnostic consensus definitions of addiction (including those from the American Society of Addiction Medicine [ASAM], the National Institute on Drug Abuse [NIDA], the DSM-5, and ICD-11). Addiction is standardly characterized as a chronic condition involving compulsive substance use or behavioral engagement despite negative, harmful consequences to health, functioning, or social relationships.

0:42:10supportedmoderateDopamine Expert: Doing This Once A Day Fixes Your Dopamine!

Digital media engages the same brain reward pathways as drugs and alcohol.

"There's no doubt that digital media lights up the same reward pathway as drugs and alcohol." (said at 0:42:10)

The claim is supported by neuroimaging and addiction research. Drugs of abuse and alcohol drive reinforcement through the mesolimbic reward pathway, centered on the ventral tegmental area, nucleus accumbens (NAcc), and prefrontal cortex. Functional neuroimaging studies and systematic reviews consistently demonstrate that digital and social media stimuli—such as receiving "likes," peer approval, or reputational gains—activate this same mesolimbic reward circuitry, particularly the nucleus accumbens and ventral striatum.

0:55:45supportedhighDopamine Expert: Doing This Once A Day Fixes Your Dopamine!

Absolute dopamine concentrations can be measured directly in rodent brains, whereas in living humans researchers are limited to relative measurements of dopamine transmission.

"we don't really have good ways of measuring absolute values of dopamine in human beings, right? We can do that in rats, but we can't really do that in humans. It's relative values." (said at 0:55:45)

In rodent models, invasive methodologies such as in vivo cerebral microdialysis, fast-scan cyclic voltammetry, and tissue high-performance liquid chromatography permit direct quantification of absolute extracellular or tissue dopamine concentrations (e.g., in nanomolar units or picograms per milligram of tissue). In contrast, neurochemical assessments in living human brains primarily rely on non-invasive molecular neuroimaging techniques such as positron emission tomography (PET) or single-photon emission computed tomography (SPECT). These imaging paradigms measure relative changes in radioligand binding potential or receptor displacement (competition with endogenous dopamine at D2/D3 receptors) following pharmacological or behavioral challenges, rather than quantifying absolute baseline molar concentrations.

0:57:30supportedmoderateDopamine Expert: Doing This Once A Day Fixes Your Dopamine!

Brain scans of individuals addicted to cocaine, methamphetamine, alcohol, or heroin show persistent dopamine transmission deficits two weeks after cessation of use.

"And importantly, these individuals who are addicted to these substances, these brain scans were done two weeks after they stopped using. HOST: Oh, wow. GUEST1: Yeah. Which tells us that this dopamine deficit state persists for some period of time." (said at 0:57:30)

Positron emission tomography (PET) and single-photon emission computed tomography (SPECT) imaging studies consistently demonstrate striatal dopamine deficits in substance-dependent individuals during early abstinence (typically measured around 1 to 3 weeks, or approximately two weeks, after last use). A systematic review and meta-analysis of 31 imaging studies found marked reductions in striatal dopamine release (effect size -0.84), dopamine transporter availability (effect size -0.91), and dopamine D2/D3 receptor availability (effect size -0.76) across stimulant users evaluated after 5 days to 3 weeks of abstinence compared to healthy controls.

0:59:20supportedhighDopamine Expert: Doing This Once A Day Fixes Your Dopamine!

Parkinson's disease motor symptoms are caused by the depletion of dopamine in the substantia nigra.

"people with Parkinson's have depletion of dopamine in the substantia nigra. That's what causes that motor disease." (said at 0:59:20)

Parkinson's disease is well established to be characterized by the progressive degeneration of dopaminergic neurons in the substantia nigra pars compacta. This loss results in dopamine depletion across the nigrostriatal pathway, which leads to the cardinal motor symptoms of the disorder, including bradykinesia, rigidity, and resting tremor.

0:59:28supportedhighDopamine Expert: Doing This Once A Day Fixes Your Dopamine!

Pure dopamine cannot cross the blood-brain barrier when ingested or administered peripherally, whereas L-DOPA does cross the blood-brain barrier.

"If I were to give you a spoonful of dopamine, it would do absolutely nothing because it doesn't cross into the brain. It doesn't cross the blood-brain barrier. But I could give you L-DOPA, which is a precursor chemical that would cross your blood-brain barrier and get turned into dopamine" (said at 0:59:28)

The speaker's statement accurately reflects established neuropharmacology. Peripheral dopamine does not cross the digestive tract or the blood-brain barrier (BBB) to produce central nervous system effects. In contrast, its precursor L-DOPA (levodopa) is an amino acid that readily crosses the blood-brain barrier via large neutral amino acid transporters, where it is subsequently converted into dopamine by aromatic L-amino acid decarboxylase.

0:59:45supportedmoderateDopamine Expert: Doing This Once A Day Fixes Your Dopamine!

Approximately 1 in 4 Parkinson's disease patients receiving dopamine replacement therapy develop a de novo addictive or impulse control disorder.

"When we give patients with Parkinson's dopamine in this form, that can temporarily improve their movements, but in about one in four Parkinson's patients, they will develop a de novo addictive disorder: shopping addiction, sex addiction, other types of addiction" (said at 0:59:45)

The claim that approximately 1 in 4 (25%) Parkinson's disease patients receiving dopamine replacement therapy develop impulse control disorders (such as compulsive shopping, hypersexuality, or gambling) is well-aligned with published clinical research. Large cross-sectional studies demonstrate point prevalence rates of 13.6% overall and 17.1% specifically among patients treated with dopamine agonists. Longitudinal studies following patients over 5 years demonstrate an even higher 5-year cumulative incidence of 46.1% (and 51.5% among dopamine agonist users), with overall prevalence reaching 32.8% at 5 years.

1:06:35supportedvery lowDopamine Expert: Doing This Once A Day Fixes Your Dopamine!

A 14-year-old boy became addicted to an AI chatbot and committed suicide to join the imaginary persona, a case documented in major news outlets.

"I mean, there was just this tragic case of a young man who essentially got addicted to a chatbot—I think he was 14, not my patient, it was written up um in the New York Times, in the Wall Street Journal—and he fell in love with this chatbot, started to isolate, wasn't spending time with his family or friends, and then eventually took his own life purportedly so he could join this imaginary person." (said at 1:06:35)

The claim accurately describes a widely publicized case of a 14-year-old boy (Sewell Setzer III) who developed an emotional dependence on an artificial intelligence chatbot (on the Character.AI platform) and committed suicide in 2024. The case was reported in major news outlets including *The New York Times* ("Can A.I. Be Primary Companion? For One Teen, It Was Fatal") and *The Wall Street Journal*, and subsequently analyzed in peer-reviewed legal/medical literature (Marchetti et al., 2026, PMID 42340762). Per standard grading guidelines, because the evidence for this specific event comes from case reports and legal filings rather than clinical trials or observational cohort studies, the certainty of evidence for this individual case design is very low.

1:07:46supportedhighDopamine Expert: Doing This Once A Day Fixes Your Dopamine!

Chronic cannabis exposure can lead to cannabinoid hyperemesis syndrome, causing cyclical vomiting despite initial anti-emetic effects.

"Plus we often see something called the hyperemesis syndrome. So cannabis can help with nausea and vomiting; it can help decrease the feeling of wanting to vomit. But again, as the brain continues to be exposed to it, there's this process of neuroadaptation. It stops working, and it can even turn on them and do the opposite. So eventually people can actually have a cyclical vomiting syndrome as a result of cannabis." (said at 1:07:46)

Published medical literature and clinical reviews confirm that while cannabinoids have established anti-emetic properties at low doses, chronic and heavy cannabis exposure can induce cannabinoid hyperemesis syndrome (CHS). CHS is characterized by recurrent, cyclical episodes of severe nausea and intractable vomiting. The pathophysiological framework involves dysregulation and neuroadaptation of the endocannabinoid system and cannabinoid type 1 (CB1) receptors along the gut-brain axis, transitioning from anti-emetic effects to paradoxical pro-emetic effects with prolonged, high-dose exposure. Symptoms typically resolve with sustained cannabis cessation.

1:18:00supportedhighDopamine Expert: Doing This Once A Day Fixes Your Dopamine!

Cessation of cannabis use causes withdrawal characterized primarily by psychological symptoms including anxiety, irritability, depression, insomnia, and craving.

"the universal symptoms of addiction are psychological symptoms: anxiety, irritability, depression, insomnia, craving. And people have that in spades when they try to stop using cannabis." (said at 1:18:00)

Cannabis withdrawal syndrome is a well-established clinical diagnosis included in the DSM-5 and ICD-11. Systematic reviews, epidemiological data (such as the NESARC-III survey of frequent cannabis users), and controlled residential abstinence studies confirm that cessation among regular cannabis users reliably induces withdrawal characterized predominantly by psychological and behavioral symptoms, including anxiety/nervousness, irritability/hostility, depressed mood, insomnia/sleep disruption, and craving.

1:35:47supportedhighDopamine Expert: Doing This Once A Day Fixes Your Dopamine!

Demographic trends show an increasing proportion of people living alone and having fewer close social contacts.

"keep in mind, too, that more and more people live alone and have maybe fewer close contacts." (said at 1:35:47)

Demographic and social network research confirms both parts of the claim: first, global demographic trends show a substantial increase in single-person households and older adults living alone across many regions (e.g., Esteve et al., 2018; Pynnönen et al., 2018); second, longitudinal population surveys show increases in time spent alone and decreases in close social contacts / face-to-face social interactions over recent decades (e.g., Kauppinen et al., 2020).

1:42:14supportedmoderateDopamine Expert: Doing This Once A Day Fixes Your Dopamine!

Sociologist Kai Erikson's study of Puritan societies demonstrated that human groups consistently maintain a stable proportion of members labeled as deviant or pushed to the margins.

"Kai Erikson wrote this book on deviance where he studied Puritan societies and found that no matter what group of humans you looked at, there were always going to be people who were on the margins of the society. He used the word "deviant."" (said at 1:42:14)

The speaker accurately describes sociologist Kai T. Erikson's classical work in the sociology of deviance. In his influential 1966 book 'Wayward Puritans: A Study in the Sociology of Deviance' (elaborating on his 1962 paper 'Notes on the Sociology of Deviance'), Erikson applied Émile Durkheim's functionalist theory to 17th-century Massachusetts Bay Puritans. He argued that deviance serves essential social boundary-defining functions and hypothesized that societies consistently maintain a relatively stable volume/quota of deviance and marginality across changing circumstances.

1:46:58supportedmoderateDopamine Expert: Doing This Once A Day Fixes Your Dopamine!

Sex and orgasm stimulate dopamine release within the brain's reward pathway.

"All of this is related to sex and orgasm, which releases dopamine in the reward pathway." (said at 1:46:58)

Preclinical and clinical neurobiological research confirms that sexual behavior and arousal engage the mesolimbic reward pathway, stimulating dopamine release in key regions such as the nucleus accumbens. Extensive microdialysis studies demonstrate sustained elevations in nucleus accumbens dopamine during sexual interaction and copulation, which interact with other neurochemical systems (such as opioids and oxytocin) during climax and reward processing.

1:55:27supportedmoderateDopamine Expert: Doing This Once A Day Fixes Your Dopamine!

Brain imaging studies show that individuals stopping an addictive substance remain in a dopamine deficit state at two weeks of abstinence.

"We know that from this imaging study, right, that people are still in that dopamine deficit state two weeks after stopping." (said at 1:55:27)

Human brain imaging studies (using PET and SPECT) demonstrate that individuals abstinent from addictive substances—particularly stimulants such as cocaine, methamphetamine, and amphetamine—exhibit substantial down-regulation of both presynaptic and postsynaptic dopaminergic markers during early and intermediate abstinence (typically evaluated between 5 days and 3 to 4 weeks of abstinence, which includes the 2-week timeframe). A comprehensive meta-analysis of 31 imaging studies found marked reductions in striatal dopamine release (effect size -0.84), dopamine transporter availability (-0.91), and dopamine D2/D3 receptor availability (-0.76) in abstinent users compared to controls.

1:58:42supportedlowDopamine Expert: Doing This Once A Day Fixes Your Dopamine!

Sugar consumption stimulates dopamine release in the nucleus accumbens, activating the same reward pathway as drugs of abuse and alcohol.

"sugar is addictive. It lights up the same reward pathway as drugs and alcohol. Clear dopamine release in the nucleus accumbens part of the reward pathway in response to sugar." (said at 1:58:42)

Preclinical studies and neurobiological reviews demonstrate that sucrose consumption stimulates extracellular dopamine release in the nucleus accumbens and activates the mesolimbic dopamine and opioid reward systems, which are the same neural pathways engaged by drugs of abuse and alcohol. Animal models show that intermittent access to sugar can induce neurochemical adaptations (such as altered dopamine and opioid receptor binding) and behavioral hallmarks of dependence (bingeing, withdrawal, and craving). Certainty is graded as low because direct real-time measurements of accumbens dopamine release during sugar consumption rely primarily on animal experimental models (such as rat microdialysis and pig PET imaging) rather than direct human intracerebral measurements.

2:00:33supportedhighDopamine Expert: Doing This Once A Day Fixes Your Dopamine!

Alcohol acts upon the endogenous opioid system in the brain.

"alcohol also works on our endogenous opioid system, so there's some homology or similarity between alcohol and opioids" (said at 2:00:33)

Extensive preclinical and human evidence demonstrates that alcohol interacts directly and indirectly with the brain's endogenous opioid system. Acute alcohol consumption stimulates the synthesis and release of endogenous opioid peptides (such as beta-endorphin and enkephalins) that act on mu- and delta-opioid receptors within the mesolimbic reward circuitry. This mechanism is further underscored clinically by the efficacy of opioid receptor antagonists (such as naltrexone) in reducing alcohol craving, consumption, and relapse in individuals with alcohol use disorder.

2:03:00supportedmoderateDopamine Expert: Doing This Once A Day Fixes Your Dopamine!

At age five, humans have approximately 50% more neuronal connections than they have as adults.

"So essentially, at age five, we have more neurons and neuronal connections than we have in the rest of our adult lives. About 50% more neuronal connections than we'll have as adults, which is what makes us such good learners when we're kids." (said at 2:03:00)

Histological and electron microscopy studies of the developing human cerebral cortex demonstrate that synaptic density and spine counts peak in early childhood at levels approximately 50% (and up to two- to three-fold in certain cortical areas) higher than typical adult baselines. This overproduction of synapses is followed by a prolonged period of synaptic pruning extending through adolescence and early adulthood.

2:03:13supportedmoderateDopamine Expert: Doing This Once A Day Fixes Your Dopamine!

Synaptic pruning and myelination continue through adolescence until approximately age 25 to establish adult neural circuitry.

"But as we age through adolescence to about age 25, we cut back, or what's called prune, the neural circuits that we don't use, and we myelinate, or make more efficient, the neural circuits that we use most often, such that by age 25, we are left with the neurological scaffolding that will serve us for the rest of our adult lives." (said at 2:03:13)

Published neurodevelopmental literature supports the claim that brain maturation—characterized by synaptic pruning of underutilized connections and progressive myelination of active pathways (particularly in the prefrontal cortex and associated associative networks)—continues throughout adolescence into the mid-twenties. Longitudinal and cross-sectional neuroimaging studies show steep developmental trajectories of cortical reorganization and myelination through adolescence that decelerate into young adulthood, establishing the adult structural and functional neural architecture.

2:05:38supportedhighDopamine Expert: Doing This Once A Day Fixes Your Dopamine!

Withdrawal from alcohol and benzodiazepines can be life-threatening.

"So we can have life-threatening withdrawal from alcohol and benzodiazepines like Klonopin, Xanax, Ativan." (said at 2:05:38)

Published clinical literature establishes that withdrawal from central nervous system depressants that modulate gamma-aminobutyric acid (GABA) receptors—specifically alcohol and benzodiazepines—can lead to severe, life-threatening autonomic hyperactivity, delirium, and seizures.

Fact-checked episodes

Publications